TigerOak Management’s Bristol-Myers Squibb BMY Stock Holding History

TigerOak Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Hold	3,627	–	–	0.06%	134
2026 Q1	$220K	Buy	+3,627	New	+$211K	0.07%	117
2025 Q2	–	Sell	-3,621	Closed	-$221K	–	116
2025 Q1	$221K	Hold	3,621	–	–	0.09%	97
2024 Q4	$205K	Buy	+3,621	New	+$202K	0.07%	103

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TigerOak Management's BMY Position: Q2 2026 in Review

TigerOak Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,627 shares worth $209K. The position accounts for 0.06% of the portfolio, ranked #134.

TigerOak Management first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. The position peaked at $221K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

TigerOak Management held 3,627 shares of Bristol-Myers Squibb worth $209K as of Q2 2026.
TigerOak Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.06% of TigerOak Management's portfolio in Q2 2026, its #134 holding.
TigerOak Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
TigerOak Management's Bristol-Myers Squibb position peaked at $221K in Q1 2025.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on TigerOak Management's 13F filing for Q2 2026, filed 11 Aug 2026.